Bloomberg Business, November 23, 2021: President Biden’s choice to lead the FDA made millions of dollars from health and drug companies since his last stint in government, raising new questions about his ties to firms the agency oversees.
Read More »Tag: FDA commissioner
The road ahead for Califf’s confirmation
Axios and Yahoo News, November 15, 2021: Former FDA chief Robert Califf has been nominated to head the agency again. We tell Axios that “The public has been asking if they can trust the FDA to ensure that the benefits outweigh the risks for Alzheimer’s drugs, cancer treatments, and implanted devices”
Read More »Biden Picks Robert Califf to Head the FDA for a Second Time
The Scientist, November 12, 2021: Former FDA Commissioner Robert Califf has been nominated to be the new FDA Commissioner. He has excellent experience, but like all the FDA candidates the White House considered recently, he has close ties to industry.
Read More »Biden to Choose Robert Califf to Lead F.D.A., Despite Drug Industry Ties
The New York Times, November 12, 2021: Is Biden nominee Dr. Califf the best choice to head up the FDA. The New York Times describes his pros and cons, and we point out that the White House doesn’t mind his Pharma ties.
Read More »Biden picks ex-FDA chief Robert Califf to again lead agency
AP News, November 12, 2021: Robert Califf will be nominated as FDA Commissioner today. We told AP “He knows how the FDA works, and he avoided making any outrageous decisions as commissioner. Those are essential if the FDA is going to regain the public trust.”
Read More »